Pharma
Dapefy SM (Dapagliflozin, Sitagliptin and Metformin ER Tablets)
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 500 mg (28 tablets) for Type 2 Diabetes.
Dapefy SM (Dapagliflozin, Sitagliptin and Metformin ER Tablets)
Dapefy SM is a triple-combination antidiabetic medication containing Dapagliflozin (SGLT2 inhibitor), Sitagliptin (DPP-4 inhibitor), and Extended-Release Metformin HCl (biguanide). This pack contains 28 tablets (4x7's Tablets). This combination works through three different mechanisms to lower blood glucose levels: increasing glucose excretion via urine, increasing insulin secretion while decreasing glucagon levels, and reducing liver glucose production. It is indicated for the treatment of type 2 diabetes mellitus when single or dual therapy is insufficient. It is designed for once-daily dosing.
You May Also Like
Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.